ReMedys established an affiliate in Russia

In 2015 ReMedys, including several renown Russian scientists, established an international consortium to be working on a neglected disease ( That was the opportunity for ReMedys to recognize; a) a strong potential in Russian scientific innovation and b) a strong need and wish of Russian Universities and Hospitals, in accessing R&D know how in biopharma.

Starting during the summer of 2016, ReMedys shall be present in Russia with an affiliate based in Novosibirsk.

The aim of ReMedys is to become the benchmark R&D arm for all innovative biopharma clinical or preclinical projects in Russia.